Alteration of the fibrinogen molecule and its phosphorylation state in myocardial infarction patients undergoing thrombolytic treatment (Q73539166)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713316%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Alteration of the fibrinogen molecule and its phosphorylation state in myocardial infarction patients undergoing thrombolytic treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713316%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

myocardial infarction

1 reference

A C Haglund

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713316%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

G Ronquist

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713316%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

G Frithz

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713316%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

P Ek

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713316%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 April 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713316%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713316%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713316%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713316%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

147-156

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713316%20AND%20SRC:MED&resulttype=core&format=json

Pharmacological approaches and strategies for therapeutic modulation of fibrinogen

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900225-X

7 January 2021

Purification and characterization of 3 fibrinogens with different molecular weights obtained from normal human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900225-X

7 January 2021

Quantitation of the three normally-occurring plasma fibrinogens in health and during so-called "acute phase" by SDS electrophoresis of fibrin obtained from EDTA-plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900225-X

7 January 2021

Human fibrinogen heterogeneity. A study of limited fibrinogen degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900225-X

7 January 2021

Amino acid sequence studies on the .alpha. chain of human fibrinogen. Overlapping sequences providing the complete sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900225-X

7 January 2021

Amino-Acid Sequence and the Occurrence of Phosphorus in Human Fibrinopeptides

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900225-X

7 January 2021

The location of a second in vivo phosphorylation site in the A alpha-chain of human fibrinogen

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900225-X

7 January 2021

On the occurrence of phosphorus in fibrinogen

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900225-X

7 January 2021

Comparison of structures of various human fibrinogens and a derivative thereof by a study of the kinetics of release of fibrinopeptides

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900225-X

7 January 2021

Increase in the degree of phosphorylation of circulating fibrinogen under thrombolytic therapy with urokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900225-X

7 January 2021

Increased phosphorylation of human fibrinopeptide A under acute phase conditions.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900225-X

7 January 2021

Increased phosphate content of fibrinogen in vivo correlates with alteration in fibrinogen behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900225-X

7 January 2021

The effects of in vitro phosphorylation and dephosphorylation on the thrombin-induced gelation and plasmin degradation of fibrinogen

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900225-X

7 January 2021

Blood rheology in acute myocardial infarction: effects of high-dose i.v. streptokinase compared to placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900225-X

7 January 2021

Rate of fibrinogen breakdown related to coronary patency and bleeding complications in patients with thrombolysis in acute myocardial infarction--results from the PRIMI trial

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900225-X

7 January 2021

Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900225-X

7 January 2021

Comparison of thrombolytic, fibrinolytic, and fibrinogenolytic properties of tissue plasminogen activator, streptokinase, single-chain urokinase, high molecular weight and low molecular weight urokinase in human plasma in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900225-X

7 January 2021

Hypercoagulable state after thrombolytic therapy in patients with acute myocardial infarction (AMI) treated with streptokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900225-X

7 January 2021

Purification of human plasma fibrinogen by chromatography on protamine-agarose

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900225-X

7 January 2021

Isolation and purification of fibrinogen/fibrin degradation products by chromatography on protamine-agarose

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900225-X

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900225-X

7 January 2021

Pharmacokinetics and systemic effects of tissue-type plasminogen activator in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900225-X

7 January 2021

Fibrinogen breakdown, long-lasting systemic fibrinolysis, and procoagulant activation during alteplase double-bolus regimen in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900225-X

7 January 2021

Pharmacodynamics of thrombolysis with recombinant tissue-type plasminogen activator. Correlation with characteristics of and clinical outcomes in patients with acute myocardial infarction. The TAMI Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900225-X

7 January 2021

Human fibrinopeptides isolation, characterization and structure

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900225-X

7 January 2021

Estimation of phosphorylation stoichiometry by separation of phosphorylated isoforms

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900225-X

7 January 2021

Protein kinase C phosphorylates pp60src at a novel site.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900225-X

7 January 2021

Altered rheological properties of blood following administrations of tissue plasminogen activator and streptokinase in patients with acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900225-X

7 January 2021

10.1016/S0049-3848(99)00225-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713316%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713316%20AND%20SRC:MED&resulttype=core&format=json